“Members of the Canadian Research Knowledge Network (CRKN) set bold negotiation objectives for the 2020 renewal with Elsevier: significantly reduce costs, increase open access, and ensure transparency of the agreement. After eleven months of negotiating, CRKN’s Content Strategy Committee (CSC) is announcing a renewal of the Elsevier ScienceDirect license, which includes:
A 12.5% reduction for 2021, followed by a 0% change for 2022, and a 2% increase for 2023. The renewed agreement maintains access to all journals in the Freedom Collection, including former Academic Press journals, and members’ subscribed titles, with no loss of perpetual access rights. This results in cost savings of US$17.4 million over three years (when compared with a three-year contract with anticipated 2% annual increases).
A 20% discount on Article Processing Charges (APCs) for both hybrid and gold open access journals. Cell Press, Lancet, and some other society-owned journals are excluded.
No confidentiality or non-disclosure clause which ensures transparency and allows the terms to be shared….”
“A number of libraries and consortia have provided the full text of Big Deal licenses. These provide useful information about the terms and conditions publisher may seek to include in their standard agreements. For tips on how to acquire additional contracts not listed here, see our “Freedom of Information Requests” guide. If you have an agreement that can be lawfully shared here, please contact us. We’ve also compilled tips on pushing back against confidentiality clauses and NDAs. …”
“Carnegie Mellon University and Elsevier Thursday announced a new agreement to radically change how the institution pays to read and publish research.
Instead of paying separately to access Elsevier’s catalog of paywalled content and publish open-access articles in Elsevier journals, Carnegie Mellon will pay one flat fee for both….
The “read-and-publish” deal is a first with a university in the U.S. for Elsevier and is the result of nearly yearlong negotiations. Elsevier struck a similar deal with a consortium of Norwegian research institutions earlier this year.
Like the Norwegian deal, the Carnegie Mellon deal is being treated as an experimental pilot by Elsevier….”